SEC Comment Letter for Lexaria Bioscience Corp. (LEXX) (CIK 0001348362) (LEXX) — Jan 19, 2018
Lexaria Bioscience Corp. (LEXX) (CIK 0001348362)
Date: Jan. 19, 2018 · CIK: 0001348362 · Accession: 0000000000-18-001924
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-222451
Letter
Mail Stop 4628 January 18, 2018 Chris Bunka Chief Execut ive Officer , Director and Chairman Lexaria Bioscience Corp. 156 Valleyview Road Kelowna, British Columbia, Canada V1X 3M4
Re: Lexaria Bioscience Corp. Registration Statement on Form S-4 Filed January 5, 2018 File No. 333-222451
Dear M r. Bunka:
This is to advise you that we have not reviewed and will not review your registration statement .
Please r efer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the s taff.
Please contact Jerard Gibson, Staff Attorney, at (202) 551 -3473 with any questions.
Sincerely,
/s/ Kevin M. Dougherty for
Show Raw Text
Mail Stop 4628 January 18, 2018 Chris Bunka Chief Execut ive Officer , Director and Chairman Lexaria Bioscience Corp. 156 Valleyview Road Kelowna, British Columbia, Canada V1X 3M4 Re: Lexaria Bioscience Corp. Registration Statement on Form S-4 Filed January 5, 2018 File No. 333-222451 Dear M r. Bunka: This is to advise you that we have not reviewed and will not review your registration statement . Please r efer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the s taff. Please contact Jerard Gibson, Staff Attorney, at (202) 551 -3473 with any questions. Sincerely, /s/ Kevin M. Dougherty for H. Roger Schwall Assistant Director Office of Natural Resources cc: William Macdonald Macdonald Tuskey